Navigation Links
CareFusion Files Amended Form 10 Registration Statement With SEC
Date:7/7/2009

SAN DIEGO, July 7 /PRNewswire-FirstCall/ -- CareFusion Corporation, the company that will become public from the planned spinoff of Cardinal Health's clinical and medical products businesses, today filed a fourth amendment to its Form 10 Registration Statement with the Securities and Exchange Commission (SEC), where it announced the receipt of the private letter ruling from the Internal Revenue Service (IRS) and an adjusted distribution ratio for the planned spinoff.

Cardinal Health has received a private letter ruling from the IRS that the planned contribution by Cardinal Health of the assets of the clinical and medical products businesses to CareFusion and the planned distribution of CareFusion common stock to Cardinal Health shareholders will qualify as a transaction that is generally tax-free for U.S. federal income tax purposes.

As part of the filing, the company also disclosed a new distribution ratio for the planned spinoff of 0.5 share of CareFusion common stock for each common share of Cardinal Health held at the record date. Based on approximately 360 million Cardinal Health common shares outstanding as of March 31, a total of approximately 180 million shares of CareFusion common stock will be distributed to Cardinal Health shareholders. As previously disclosed, Cardinal Health will retain up to 19.9 percent of CareFusion's outstanding common stock, which equals approximately 45 million additional shares. Cardinal Health will divest all CareFusion shares within five years of completing the spinoff.

"The decision to modify the distribution ratio was driven by a preference to have fewer shares outstanding, allowing CareFusion to enter the market with a share price that is more consistent with other large-cap med tech companies and providing what we believe will be greater liquidity to our future shareholders," said David Schlotterbeck, CEO of CareFusion. "The receipt of the private letter ruling is a
'/>"/>

SOURCE Cardinal Health, Inc.; CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CareFusion Corporation Files Form 10 Registration Statement
2. CareFusion Names Edward Borkowski as Chief Financial Officer
3. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
4. CareFusion Names Robert Friel to Board of Directors
5. CareFusion Launches New Brand, Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety
6. Alvarado Hospital Files Countersuit Against Blue Shield
7. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
8. Pharsight Files Application for Nasdaq Capital Market Listing
9. Gentiva(R) Health Services Files Universal Shelf Registration Statement
10. Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx
11. CIGNA Behavioral Health Offers Members Online Provider Profiles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... (HealthDay News) -- Researchers report that children with autism ... in their brains compared with typical children. The ... the number of extra synapses through drug treatment. ... cells (neurons) connect and communicate with each other. Having ... the brain functions, theorized neuroscientists at Columbia University Medical ...
(Date:8/21/2014)... Angeles, CA (PRWEB) August 21, 2014 ... talk show “Heavy Metal Greg” will screen on Monday, ... Action on Film International Film Festival. This festival is ... several companies, including Video Symphony, Sony Software, Avid, and ... California, at Cinema 12 & LFX, located at 410 ...
(Date:8/21/2014)... and health authorities need to ensure that experimental drugs ... context of randomized controlled trials, according to a new ... 21 August, 2014]. , Leading bioethicists Professor ... and Dr Annette Rid, of King,s College London, UK, ... to if experimental drugs are to be deployed in ...
(Date:8/21/2014)... One of the emerging trends that the Intranasal ... increasing adoption of non-invasive administration products. As non-invasive nasal ... their convenient application, they find more preference among end-users. ... used for the administration of drugs for the treatment ... such as allergic and non-allergic rhinitis and sinusitis. The ...
(Date:8/21/2014)... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast, 2012 - 2018," the ... million in 2011 and is estimated to reach a ... CAGR of 6.3% from 2012 to 2018. , Browse ... , Fundus cameras market growth in recent years has ...
Breaking Medicine News(10 mins):Health News:Kids With Autism Have Extra Brain Connections, Study Says 2Health News:“Heavy Metal Greg,” a Music Talk Show by Gregory Graham, Will Screen at Action on Film International Film Festival on 08/25/2014 2Health News:The Lancet: Experimental Ebola drugs must be fairly distributed and tested ethically in clinical trials 2Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 2Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 3Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 4Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 5Health News:Fundus Cameras Market: Product Type- Mydriatic, Non-Mydriatic, Hybrid and ROP Cameras; End Users- Hospitals, Ophthalmology Clinics and Ophthalmic & Optometrist Offices 2
... Fitness Event at the Quicken Loans Arena on June 18th -- Join ... ... LeBron James and Mayor Frank Jackson,invite Cleveland residents to join a ... well-being with a FREE,health and fitness plan -- the Cleveland City Challenge. ...
... Manpower Support Cutting-Edge ... Manufacturing Activities, SAN ... a leading manufacturing hub in Asia with its strong,track record, ... output expanded,four-fold from US$4.4 billion in 2000 to US$17 billion ...
... Inc. Director of Internal Controls Adds to SAND,s ... ... SAND Technology Inc. (OTC,Bulletin Board: SNDTF), an international provider ... Schwartz,has joined the firm as Chief Financial Officer and Vice ...
... off diabetes meds and into remission, study found , , ... a major role in improving diabetes after obese patients ... , Previous studies have suggested that gastric bypass ... the stomach to the small intestine -- helps improve ...
... University of Florida department of urology officials ... German biopharmaceutical company CureVac to test an experimental ... longer respond to traditional treatment. , CureVac ... RNA, a biomolecule that transfers genetic information from ...
... over the last fifteen years in national accreditation guidelines ... a right, there is no evidence yet that this ... hospitals with chaplains. Rather, new research from Brandeis University ... Journal reports that whether hospitals had a chaplain ...
Cached Medicine News:Health News:NBA All-Star and Olympic Athlete LeBron James and Dr. Ian Smith Celebrate the Launch of The 50 Million Pound Challenge's First 'Citywide Team Challenge,' Kicking off in Cleveland, Ohio 2Health News:NBA All-Star and Olympic Athlete LeBron James and Dr. Ian Smith Celebrate the Launch of The 50 Million Pound Challenge's First 'Citywide Team Challenge,' Kicking off in Cleveland, Ohio 3Health News:Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion 2Health News:Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion 3Health News:Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion 4Health News:SAND Technology Appoints Zainab Ahmed Schwartz as CFO 2Health News:Weight Loss After Gastric Bypass Is Key to Easing Diabetes 2Health News:UF scientists to work with German firm in prostate cancer treatment research 2Health News:When the spirit moves into the hospital 2
(Date:8/21/2014)... Aug. 21, 2014   Auxilium Pharmaceuticals, Inc. ... biopharmaceutical company, today announced positive results from a ... histolyticum (or CCH) for the treatment of edematous ... the Phase 2a trial, all three doses of ... showed an improvement in the appearance of cellulite ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)... 20, 2014  The National Association of Drug ... achieved by the real-time, pseudoephedrine (PSE) blocking system ... Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales ... offenders and make arrests. Data released by NPLEx ... blocked the sale of more than 32,890 ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 26, 2011 Endo Pharmaceuticals Holdings Inc. (NASDAQ: ... aggregate principal amount of senior unsecured notes. The notes will ... guaranteed by certain of the Company,s subsidiaries.   ... together with cash on hand and borrowings under its new ...
... May 26, 2011 Hospital and health-system pharmacies ... shortages and promote patient safety with the support ... Technicians (CPhTs). Manufacturing issues, including shortages ... limited manufacturing capacity, and pharmaceutical industry consolidation, have ...
Cached Medicine Technology:Endo Pharmaceuticals Holdings Inc. Announces Proposed Private Offering of Senior Notes 2Pharmacy Technicians Assist Pharmacy Teams in Development of Drug Shortage Protocols 2
For use under silicone strips E5381 610, E5381 611 and E5381 710. Indications: When higher buckle is required. Overall length: 6.1 mm....
Ungrooved permanent silicone strip. Indications: For trapdoor procedure. Overall length: 125 mm, 4.9 inches....
Concave inner surface to conform to the globe. Indications: Wide scleral bed. Outside diameter 32 mm....
Concave inner surface to conform to the globe. Used in conjunction with the E5381 600 Circling Band (240 style). Indications: Wide scleral bed. Outside diameter 31.7 mm....
Medicine Products: